Plus Therapeutics Regains Compliance with Nasdaq Minimal Bid Worth Requirement
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV)…
GCL Pronounces Receipt of Nasdaq Deficiency Realize Relating to Minimal Bid Value Requirement
SINGAPORE, March 23, 2026 (GLOBE NEWSWIRE) -- GCL International Holdings Ltd (Nasdaq:…
